MiR-429 regulates alveolar macrophage inflammatory cytokine production and is involved in LPS-induced acute lung injury

Biochemical Journal

Volumn 471, Issue 2, 2015, Pages 281-291

  Xiao, Ji ^a   Tang, Jing ^a,b   Chen, Quan ^a   Tang, Dan ^a   Liu, Meimei ^a   Luo, Min ^a   Wang, Yan ^a   Wang, Jiazheng ^a   Zhao, Zhenyu ^a   Tang, Chaoke ^a   Wang, Deming ^a   Mo, Zhongcheng ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Maternal and Child Health Hospital of Hunan Province   (China)

Author keywords

Cytokine; Dual specificity phosphatase 1; Lipopolysaccharide; MiR 429; Mitogen activated protein kinase

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 141; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 429; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE P38;

3' UNTRANSLATED REGION; ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RNA TRANSLATION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; MICRORNAS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84943176682     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20131510     Document Type: Article

References (34)

1. Goodman, R. B., Pugin, J., Lee, J. S. and Matthay, M. A. (2003) Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 14, 523-535
2. Perl, M., Lomas-Neira, J., Venet, F., Chung, C. S. and Ayala, A. (2011) Pathogenesis of indirect (secondary) acute lung injury. Expert Rev. Respir. Med. 5, 115-126
3. Dreyfuss, D. and Ricard, J. D. (2005) Acute lung injury and bacterial infection. Clin. Chest Med. 26, 105-112
4. Altmann, C., Andres-Hernando, A., McMahan, R. H., Ahuja, N., He, Z., Rivard, C. J., Edelstein, C. L., Barthel, L., Janssen, W. J. and Faubel, S. (2012) Macrophages mediate lung inflammation in a mouse model of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 302, F421-F432
5. Herold, S., Mayer, K. and Lohmeyer, J. (2011) Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front. Immunol. 2, 65
6. Bode, J. G., Ehlting, C. and Haussinger, D. (2012) The macrophage response towards LPS and its control through the p38MAPK-STAT3 axis. Cell. Signal. 24, 1185-1194
7. van den Blink, B., Juffermans, N. P., ten Hove, T., Schultz, M. J., van Deventer, S. J., van der Poll, T. and Peppelenbosch, M. P. (2001) p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo. J. Immunol. 166, 582-587
8. Chen, C., Chen, Y. H. and Lin, W. W. (1999) Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 97, 124-129
9. Lang, R., Hammer, M. and Mages, J. (2006) DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J. Immunol. 177, 7497-7504
10. Hammer, M., Mages, J., Dietrich, H., Servatius, A., Howells, N., Cato, A. C. and Lang, R. (2006) Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 203, 15-20
11. Chen, K. and Rajewsky, N. (2007) The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 8, 93-103
12. He, L. and Hannon, G. J. (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531
13. O'Connell, R. M., Rao, D. S. and Baltimore, D. (2012) microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30, 295-312
14. Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y. and Goodall, G. J. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601
15. Brabletz, S. and Brabletz, T. (2010) The ZEB/miR-200 feedback loop: a motor of cellular plasticity in development and cancer? EMBO Rep. 11, 670-677
16. Reddy, M. A., Jin, W., Villeneuve, L., Wang, M., Lanting, L., Todorov, I., Kato, M. and Natarajan, R. (2012) Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice. Arterioscler. Thromb. Vasc. Biol. 32, 721-729
17. Wang, D., Liu, M., Wang, Y., Luo, M., Wang, J., Dai, C., Yan, P., Zhang, X., Tang, C. and Xiao, J. (2011) Synthetic LXR agonist T0901317 attenuates lipopolysaccharide-induced acute lung injury in rats. Int. Immunopharmacol. 11, 2098-2103
18. Thompson, B. T. and Matthay, M. A. (2013) The Berlin definition of ARDS versus pathological evidence of diffuse alveolar damage. Am. J. Respir. Crit. Care Med. 187, 675-677
19. Zhu, Q. Y., Liu, Q., Chen, J. X., Lan, K. and Ge, B. X. (2010) MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J. Immunol. 185, 7435-7442
20. Park, W. Y., Goodman, R. B., Steinberg, K. P., Ruzinski, J. T., Radella, 2nd, F., Park, D. R., Pugin, J., Skerrett, S. J., Hudson, L. D. and Martin, T. R. (2001) Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 164, 1896-1903
21. Gunzl, P., Bauer, K., Hainzl, E., Matt, U., Dillinger, B., Mahr, B., Knapp, S., Binder, B. R. and Schabbauer, G. (2010) Anti-inflammatory properties of the PI3K pathway are mediated by IL-10/DUSP regulation. J. Leukoc. Biol. 88, 1259-1269
22. Manetsch, M., Che, W., Seidel, P., Chen, Y. and Ammit, A. J. (2012) MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells. Cell. Signal. 24, 907-913
23. Tucsek, Z., Radnai, B., Racz, B., Debreceni, B., Priber, J. K., Dolowschiak, T., Palkovics, T., Gallyas, Jr, F., Sumegi, B. and Veres, B. (2011) Suppressing LPS-induced early signal transduction in macrophages by a polyphenol degradation product: a critical role of MKP-1. J. Leukoc. Biol. 89, 105-111
24. Cargnello, M. and Roux, P. P. (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 75, 50-83
25. Taganov, K. D., Boldin, M. P., Chang, K. J. and Baltimore, D. (2006) NF-êB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103, 12481-12486
26. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G. and Baltimore, D. (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U. S. A. 104, 1604-1609
27. McCall, C. E., El Gazzar, M., Liu, T., Vachharajani, V. and Yoza, B. (2011) Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation. J. Leukoc. Biol. 90, 439-446
28. Nahid, M. A., Satoh, M. and Chan, E. K. (2011) MicroRNA in TLR signaling and endotoxin tolerance. Cell. Mol. Immunol. 8, 388-403
29. Leskela, S., Leandro-Garcia, L. J., Mendiola, M., Barriuso, J., Inglada-Perez, L., Munoz, I., Martinez-Delgado, B., Redondo, A., de Santiago, J., Robledo, M. et al. (2011) The miR-200 family controls α-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr. Relat. Cancer 18, 85-95
30. Wiklund, E. D., Bramsen, J. B., Hulf, T., Dyrskjot, L., Ramanathan, R., Hansen, T. B., Villadsen, S. B., Gao, S., Ostenfeld, M. S., Borre, M. et al. (2011) Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int. J. Cancer 128, 1327-1334
31. Angus, D. C. and van der Poll, T. (2013) Severe sepsis and septic shock. N. Engl. J. Med. 369, 840-851
32. Osuchowski, M. F., Welch, K., Siddiqui, J. and Remick, D. G. (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177, 1967-1974
33. Abraham, E., Laterre, P. F., Garbino, J., Pingleton, S., Butler, T., Dugernier, T., Margolis, B., Kudsk, K., Zimmerli, W., Anderson, P. et al. (2001) Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1, 342 patients. Crit. Care Med. 29, 503-510
34. Fukunaga, K., Kohli, P., Bonnans, C., Fredenburgh, L. E. and Levy, B. D. (2005) Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J. Immunol. 174, 5033-5039